Loda M - Search Results

1

Tumor expression of adiponectin receptor 2 and lethal prostate cancer.

Rider JR, Fiorentino M, Kelly R, Gerke T, Jordahl K, Sinnott JA, Giovannucci EL, Loda M, Mucci LA, Finn S; Transdisciplinary Prostate Cancer Partnership (ToPCaP). Rider JR, et al. Among authors: loda m. Carcinogenesis. 2015 Jun;36(6):639-47. doi: 10.1093/carcin/bgv048. Epub 2015 Apr 11. Carcinogenesis. 2015. PMID: 25863129 Free PMC article.

2

Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.

Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M. Magi-Galluzzi C, et al. Among authors: loda m. Lab Invest. 1997 Jan;76(1):37-51. Lab Invest. 1997. PMID: 9010448

3

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M. Loda M, et al. Nat Med. 1997 Feb;3(2):231-4. doi: 10.1038/nm0297-231. Nat Med. 1997. PMID: 9018245

4

Association between sucrase-isomaltase and p53 expression in colorectal cancer.

Lise M, Loda M, Fiorentino M, Mercurio AM, Summerhayes IC, Lavin PT, Jessup JM. Lise M, et al. Among authors: loda m. Ann Surg Oncol. 1997 Mar;4(2):176-83. doi: 10.1007/BF02303802. Ann Surg Oncol. 1997. PMID: 9084856

5

Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma.

Fiorentino M, Altimari A, D'Errico A, Cukor B, Barozzi C, Loda M, Grigioni WF. Fiorentino M, et al. Among authors: loda m. Clin Cancer Res. 2000 Oct;6(10):3966-72. Clin Cancer Res. 2000. PMID: 11051245

6

Gene expression correlates of clinical prostate cancer behavior.

Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR, Sellers WR. Singh D, et al. Among authors: loda m. Cancer Cell. 2002 Mar;1(2):203-9. doi: 10.1016/s1535-6108(02)00030-2. Cancer Cell. 2002. PMID: 12086878 Free article.

7

Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.

Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, Bubley G, Balk S, Loda M. Rossi S, et al. Among authors: loda m. Mol Cancer Res. 2003 Aug;1(10):707-15. Mol Cancer Res. 2003. PMID: 12939396

8

The isopeptidase USP2a protects human prostate cancer from apoptosis.

Priolo C, Tang D, Brahamandan M, Benassi B, Sicinska E, Ogino S, Farsetti A, Porrello A, Finn S, Zimmermann J, Febbo P, Loda M. Priolo C, et al. Among authors: loda m. Cancer Res. 2006 Sep 1;66(17):8625-32. doi: 10.1158/0008-5472.CAN-06-1374. Cancer Res. 2006. PMID: 16951176

9

Prostate cancer: Re-focusing on androgen receptor signaling.

Nieto M, Finn S, Loda M, Hahn WC. Nieto M, et al. Among authors: loda m. Int J Biochem Cell Biol. 2007;39(9):1562-8. doi: 10.1016/j.biocel.2007.01.005. Epub 2007 Jan 20. Int J Biochem Cell Biol. 2007. PMID: 17321194 Free PMC article. Review.

10

Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients.

Flavin RJ, Smyth PC, Finn SP, Laios A, O'Toole SA, Barrett C, Ring M, Denning KM, Li J, Aherne ST, Aziz NA, Alhadi A, Sheppard BL, Loda M, Martin C, Sheils OM, O'Leary JJ. Flavin RJ, et al. Among authors: loda m. Mod Pathol. 2008 Jun;21(6):676-84. doi: 10.1038/modpathol.2008.33. Epub 2008 Mar 7. Mod Pathol. 2008. PMID: 18327211 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

494 results

Search Page